Plan to Ensure Taxpayers Interests are Protected

The National Institutes of Health (NIH) issued the plan that calls for little or no modification to the Institutes existing efforts to capture royalties on federally-funded research. In conducting the report, NIH found that only four of the 47 FDA-approved drugs with $500 million per year in sales were partly developed with NIH-funded technologies.